Biogen Inc.
SYFOVRE
geographic atrophy secondary to age-related macular degeneration
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on SYFOVRE for geographic atrophy secondary to age-related macular degeneration is expected Date TBD.
Primary source
· SEC 8-K
verified 14h ago
“SYFOVRE is approved in the United States and Australia.”